CN104524275B - 一种促进膀胱癌术后恢复的中药片剂及其制备方法 - Google Patents
一种促进膀胱癌术后恢复的中药片剂及其制备方法 Download PDFInfo
- Publication number
- CN104524275B CN104524275B CN201410788961.3A CN201410788961A CN104524275B CN 104524275 B CN104524275 B CN 104524275B CN 201410788961 A CN201410788961 A CN 201410788961A CN 104524275 B CN104524275 B CN 104524275B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicinal
- medicinal tablet
- hippocampus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000002980 postoperative effect Effects 0.000 title claims abstract description 33
- 238000011084 recovery Methods 0.000 title claims abstract description 26
- 230000001737 promoting effect Effects 0.000 title claims abstract description 23
- 201000001531 bladder carcinoma Diseases 0.000 title claims abstract description 20
- 208000010570 urinary bladder carcinoma Diseases 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 41
- 210000001320 hippocampus Anatomy 0.000 claims abstract description 31
- 229940079593 drug Drugs 0.000 claims abstract description 28
- 241000405414 Rehmannia Species 0.000 claims abstract description 19
- 241000576429 Forsythia suspensa Species 0.000 claims abstract description 16
- 240000008027 Akebia quinata Species 0.000 claims abstract description 15
- 235000007756 Akebia quinata Nutrition 0.000 claims abstract description 15
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 15
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 15
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 15
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 15
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 239000010231 banlangen Substances 0.000 claims abstract description 15
- 239000002775 capsule Substances 0.000 claims abstract description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 14
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 claims abstract description 14
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 14
- 239000000454 talc Substances 0.000 claims abstract description 14
- 235000012222 talc Nutrition 0.000 claims abstract description 14
- 229910052623 talc Inorganic materials 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 23
- 241000218691 Cupressaceae Species 0.000 claims description 13
- 241000207925 Leonurus Species 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 238000003860 storage Methods 0.000 claims description 10
- 239000000314 lubricant Substances 0.000 claims description 8
- 239000007884 disintegrant Substances 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 229910000503 Na-aluminosilicate Inorganic materials 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 3
- 239000008116 calcium stearate Substances 0.000 claims description 3
- 235000013539 calcium stearate Nutrition 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000000429 sodium aluminium silicate Substances 0.000 claims description 3
- 235000012217 sodium aluminium silicate Nutrition 0.000 claims description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- -1 glidant Substances 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229960004793 sucrose Drugs 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 20
- 238000000034 method Methods 0.000 abstract description 14
- 210000003932 urinary bladder Anatomy 0.000 abstract description 14
- 210000000952 spleen Anatomy 0.000 abstract description 13
- 230000010412 perfusion Effects 0.000 abstract description 12
- 208000019206 urinary tract infection Diseases 0.000 abstract description 12
- 208000004880 Polyuria Diseases 0.000 abstract description 9
- 230000005784 autoimmunity Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000035619 diuresis Effects 0.000 abstract description 9
- 238000010926 purge Methods 0.000 abstract description 8
- 230000001960 triggered effect Effects 0.000 abstract description 8
- 206010037660 Pyrexia Diseases 0.000 abstract description 5
- 201000011510 cancer Diseases 0.000 abstract description 5
- 206010028980 Neoplasm Diseases 0.000 abstract description 4
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 19
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 14
- 230000027939 micturition Effects 0.000 description 14
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 9
- 238000002271 resection Methods 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 241000193830 Bacillus <bacterium> Species 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000006750 hematuria Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 238000007086 side reaction Methods 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- 208000021760 high fever Diseases 0.000 description 4
- 230000002262 irrigation Effects 0.000 description 4
- 238000003973 irrigation Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010005003 Bladder cancer Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 201000005112 urinary bladder cancer Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010063057 Cystitis noninfective Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 240000007890 Leonurus cardiaca Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000003139 chronic cystitis Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 201000003146 cystitis Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000002632 myometrial effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010006049 Bovine Tuberculosis Diseases 0.000 description 1
- 241001674345 Callitropsis nootkatensis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001467552 Mycobacterium bovis BCG Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种促进膀胱癌术后恢复的中药片剂及其制备方法,制成该片剂有效成分的原料药组成为:西洋参,黄精,当归,益母草,海马,枸杞,黄芪,蟹壳,炙甘草,木通,萹蓄,黄柏,连翘,熟地黄,生地黄,白芷,滑石,板蓝根,白茅根,黄芩,牵牛子。该中药片剂通过预防和治疗患者术后膀胱灌注治疗的并发症和提高患者自身免疫力来促进患者术后康复。采用固本培元、健脾滋阴、补肾养血、泻火解毒、清热利尿、活血化瘀、补气升阳的方法,可以有效的预防和治疗卡介苗灌注所引发的并发症,以及灌注操作所引发的尿路感染,提高患者自身免疫力,减小患者痛苦,促进患者术后恢复,抑制癌症复发。
Description
技术领域
本发明涉及一种促进膀胱癌术后恢复的中药片剂及其制备方法,属于中药制剂技术领域。
背景技术
膀胱癌是指来源于膀胱壁上皮组织和间质组织的恶性肿瘤,是泌尿系统最常见的恶性肿瘤,占我国泌尿生殖系肿瘤发病率的第一位。外科手术是目前治疗膀胱癌的主要方式。其中,对非肌层浸润性膀胱肿瘤首选经尿道膀胱肿瘤电切术进行治疗。采用这种微创的手术,患者身体表面没有刀口,术后恢复很快。经尿道膀胱肿瘤电切术需在术后配合以膀胱灌注治疗。在灌注过程中会因为操作不当而引起尿路感染引发并发症,也可能因为药物作用而引起并发症,其中,药物作用引起的并发症多是由卡介苗造成的。这些并发症一旦发生往往会打乱患者既定的治疗方案,极大的影响患者身体健康,延长术后恢复的时间。
卡介苗是治疗膀胱肿瘤常用的免疫治疗灌注药物。卡介苗灌注膀胱后可被膀胱粘膜吸附并介导免疫应答引起炎症反应,这种免疫反应可以破坏肿瘤细胞并防止其复发及进展。卡介苗是目前公认治疗非肌层浸润性膀胱癌最为有效的药物。被视为治疗原位癌最为有效的治疗手段。虽然卡介苗灌注效果显著,但其灌注治疗副作用同样不可忽视。卡介苗灌注所引发的副作用主要表现为局部副反应和全身副反应。局部副反应的症状主要表现为尿频尿急尿痛,严重的还会出现血尿症状。全身副反应的成因是因为卡介苗属于减活疫苗,其中尚有活性的结核杆菌可直接通过膀胱粘膜的吸收或通过手术创面的开放血管进入循环,导致全身性副反应的出现。少量的卡介苗吸收,可表现为低热、盗汗、肌肉酸痛等轻度的结核菌感染症状,可伴有膀胱刺激症状,如有活性的结核杆菌透过开放的血管床被大量吸收,严重还可导致结核性败血症。除了药物引起的并发症,
发明内容
本发明的目的是预防和治疗经尿道膀胱肿瘤电切术后的卡介苗灌注治疗的并发症,以及灌注操作所引发的尿路感染,促进膀胱癌患者术后恢复,减轻患者痛苦。从针对病症和调理机体增强患者自身免疫力两方面出发,采用固本培元、健脾滋阴、补肾养血、泻火利尿、清热解毒、活血化瘀、补气升阳的方法。
为了实现上述目的本发明从针对单个病症和全面调理机体增强自身免疫力两方面考虑提供了一种促进膀胱癌术后恢复的中药片剂,该中药片剂采用固本培元、健脾滋阴、补肾养血、泻火解毒、清热利尿、活血化瘀、补气升阳的方法,可以有效的预防和治疗卡介苗灌注所引发的并发症,以及灌注操作所引发的尿路感染,提高患者自身免疫力,减小患者痛苦,促进患者术后恢复。
本发明提供了一种促进膀胱癌术后恢复的中药片剂,由中药原料药和药物可接受的载体加工制备而成,所述中药片剂有效成分的原料药组成及重量份数为:西洋参8-15份,黄精5-10份,当归10-15份,益母草7-15份,海马3-9份,枸杞15-20份,黄芪10-20份,蟹壳3-8份,炙甘草8-15份,木通9-16份,萹蓄8-12份,黄柏6-12份,连翘8-13份,熟地黄7-15份,生地黄6-10份,白芷6-12份,滑石2-5份,板蓝根15-25份,白茅根3-8份,黄芩6-10份,牵牛子5-10份。
进一步的,所述中药片剂有效成分的原料药组成及重量份数为:西洋参8份,黄精5份,当归10份,益母草7份,海马3份,枸杞15份,黄芪10份,蟹壳3份,炙甘草8份,木通9份,萹蓄8份,黄柏6份,连翘8份,熟地黄7份,生地黄6份,白芷6份,滑石2份,板蓝根15份,白茅根3份,黄芩6份,牵牛子5份。
进一步的,所述中药片剂有效成分的原料药组成及重量份数为:西洋参15份,黄精10份,当归15份,益母草15份,海马9份,枸杞20份,黄芪20份,蟹壳8份,炙甘草15份,木通16份,萹蓄12份,黄柏12份,连翘13份,熟地黄15份,生地黄10份,白芷12份,滑石5份,板蓝根25份,白茅根8份,黄芩10份,牵牛子10份。
进一步的,所述中药片剂有效成分的原料药组成及重量份数为:西洋参13份,黄精8份,当归12份,益母草10份,海马6份,枸杞17份,黄芪15份,蟹壳6份,炙甘草12份,木通13份,萹蓄10份,黄柏9份,连翘10份,熟地黄12份,生地黄8份,白芷8份,滑石3份,板蓝根20份,白茅根5份,黄芩8份,牵牛子7份。
进一步的,所述药物可接受的载体包括:粘合剂,崩解剂,助流剂、润滑剂中的一种或两种;其中,所述粘合剂可以为淀粉、糊精、麦芽糖糊精、羧甲基纤维素、蔗糖、海藻酸及海藻酸盐、黄原胶;其中,所述崩解剂可以为交联聚乙烯吡咯烷酮、羧甲基淀粉和大豆多糖;其中,所述助流剂可以为微粉硅胶、滑石粉和水合硅铝酸钠;其中,所述润滑剂可以为硬脂酸镁、硬脂酸钙、聚乙二醇、氢化植物油。
本发明还提供了所述的促进膀胱癌术后恢复的中药片剂的制备方法,包括以下步骤:
步骤1:蟹壳培黄后研末,得蟹壳粉,海马研末得海马粉;
步骤2:将步骤1中得到的蟹壳粉和海马粉以及其他原料药加入重量倍数为9倍的水,煎煮两次,每次煎煮30-60分钟,煎煮后过滤;合并两次的滤液,浓缩至相对密度为1.00~1.10(60℃),得浓缩液,加入乙醇使乙醇的质量分数达65%,搅匀,静置24~48小时,过滤并回收乙醇,浓缩至相对密度为1.15~1.25(60℃)的稠膏;
步骤3:向步骤2制得的稠膏中加入所述药物可接受的载体,混合,制粒,干燥,压片即得。
本发明为了预防和治疗经尿道膀胱肿瘤电切术后的卡介苗灌注治疗的并发症,促进膀胱癌患者术后恢复,减轻患者痛苦,采用固本培元、健脾滋阴、补肾养血、泻火利尿、清热解毒、活血化瘀、补气升阳的方法,在针对单个病症进行治疗的同时,全面调理机体增强自身免疫力。根据中医药理论辨证论治,通过大量实验筛选中药原料,精炼制剂方法,使得各药物功效产生协同作用,从而达到标本兼治的效果。选取的原料药中,西洋参补气养阴,清热生津,用于气虚阴亏,虚热烦倦,消渴,抗疲劳;黄精滋肾润脾,补脾益气,具有益肾、健脾、养阴、润肺的功效,可用于治疗脾胃虚弱,精血不足,体虚乏力;当归补血活血,调经止痛,润肠通便;益母草活血调经,行血散瘀,利尿,主治月经不调,产后血瘀腹痛,水肿,小便不利;海马温肾壮阳,散结消肿,用于阳痿,遗尿,肾虚作喘,症瘕积聚,跌扑损伤;枸杞滋补肝肾,益精明目,用于虚劳精亏,腰膝酸痛,眩晕耳鸣,阳萎遗精,内热消渴,血虚萎黄,目昏不明;黄芪性温,味甘,补气升阳,益卫固表、托毒生肌、利水退肿,主治脾胃虚弱,食少;蟹壳破瘀消积,治瘀血积滞,胁痛、腹痛,乳痈,冻疮,其含有的甲壳素可以迅速的在体内吸附油脂,并排出体外,具有降血脂、降血压、改善糖尿病、抗肿瘤、改善便秘等作用;炙甘草性甘温,归脾、胃、肺经,具有益气补虚,化痰止咳,缓急止痛,益阴生阳,用于药性峻猛的方剂中,能缓和烈性或减轻毒副作用,又可调和脾胃;木通具有泻火行水、通利血脉、通经下乳的功效,主治膀胱湿热,小便短赤热痛,口疮,心烦失眠等;黄柏具有清热燥湿、泻火除蒸、解毒疗疮的功效;萹蓄具有苦降下行、通利膀胱、苦燥、杀虫除湿止痒的功效,主治小便不利,尿道涩痛,湿疮;连翘具有清热解毒、散结消肿的功效,连翘浓缩煎剂在体外有抗菌作用,可抑制伤寒杆菌、副伤寒杆菌、大肠杆菌、痢疾杆菌、白喉杆菌及霍乱弧菌、葡萄球菌、链球菌等;熟地黄滋阴补血,益精填髓,熟地黄所含的地黄多糖具有明显的免疫瘤活性,还具有强心、利尿、保肝、降血糖、抗增生、抗渗出、抗炎、抗真菌、抗放射等作用;白芷祛风散寒,通窍止痛,消肿排脓,燥湿止带,利血脉,祛风散寒,除湿通络,白芷对大肠杆菌、痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、绿脓杆菌、霍乱弧菌、人型结核杆菌等均有抑制作用;滑石具有利尿通淋、清热解暑、祛湿敛疮的功效;生地黄具有清热凉血、养阴生津、止痛调经的功效,主治热入营血,身热口干,尿路感染;白茅根凉血止血,清热利尿,主治吐血,尿血,热淋,水肿,小便不利等;板蓝根清热解毒,凉血,主治感冒发热,斑疹,丹毒,疮痈肿毒;黄芩清热燥湿,泻火解毒,止血,安胎,主治湿热所致黄疸,泻痢,热淋,痈肿疮毒,壮热烦渴,肺热咳嗽,高热烦渴;牵牛子泻下逐水,消痰涤饮,杀虫攻积,主治水肿胀满二便不利,痰饮咳喘,虫积腹痛。
这些原料药中西洋参、黄精、当归、益母草、海马、枸杞、黄芪、生地黄协同作用有健脾滋阴、补肾养血、活血化瘀、补气生阳的功效,其中,海马与枸杞相伍可增益其补肾效果,牵牛子与海马相伍可增益行气散结之功,这些药材可以从整体上调节机体,增强患者自身免疫力,减轻患者的体虚盗汗症状,促进患者康复,防止患者因脾肾阴虚而感染卡介苗中上有活性的结核杆菌,预防全身副反应;益母草、木通、萹蓄、滑石、白茅根、牵牛子都具备泻火利尿的作用,可以有效的预防和治疗局部副反应中尿频、尿急、尿痛、尿血的症状;萹蓄、黄柏、连翘、熟地黄、白芷、生地、板蓝根都具有抗菌功效,可以有效的预防和治疗灌注操作所引起的尿路感染;木通、黄柏、连翘、生地黄、板蓝根、白茅根、黄芩都具有清热解毒的功效,可以治疗和预防由卡介苗灌注引起的并发症或尿路感染引发的发热症状;熟地黄和蟹壳还具有抗肿瘤的作用,可抑制癌症复发;炙甘草在其中可以起到和中益气,调和药性,缓急止痛作用。以上诸药合用,可以预防和治疗膀胱癌术后膀胱灌注治疗所引起的尿路感染和卡介苗灌注引起的并发症,固本培元,提高患者自身免疫力,促进术后恢复,并且诸药相互调理,对机体不良影响小,临床应用更加安全有效。
本发明的有益效果为:本发明提供了一种促进膀胱癌术后恢复的中药片剂。该中药片剂通过预防和治疗患者术后膀胱灌注治疗的并发症和提高患者自身免疫力来促进患者术后康复。采用固本培元、健脾滋阴、补肾养血、泻火解毒、清热利尿、活血化瘀、补气升阳的方法,可以有效的预防和治疗卡介苗灌注所引发的并发症,以及灌注操作所引发的尿路感染,提高患者自身免疫力,减小患者痛苦,促进患者术后恢复。同时,该片剂中还含有抗肿瘤的成分可以起到一定的抑制癌症复发的作用。
具体实施方式
根据下述实施例,可以更好地理解本发明。然而,本领域的技术人员容易理解,实施例所描述的具体的物料配比、工艺条件及其结果仅用于说明本发明而不应当也不会限制权利要求书中所详细描述的本发明。
实施例1制备促进膀胱癌术后恢复的中药片剂
配方:
原料药:西洋参8克,黄精5克,当归10克,益母草7克,海马3克,枸杞15克,黄芪10克,蟹壳3克,炙甘草8克,木通9克,萹蓄8克,黄柏6克,连翘8克,熟地黄7克,生地黄6克,白芷6克,滑石2克,板蓝根15克,白茅根3克,黄芩6克,牵牛子5克。
辅料:羧甲基纤维素(粘合剂)6克,
交联聚乙烯吡咯烷酮(崩解剂)6克,
微粉硅胶(助流剂)1克,
硬脂酸镁(润滑剂)1克
配制方法为:
步骤1:蟹壳培黄后研末,得蟹壳粉,海马研末得海马粉;
步骤2:将步骤1中得到的蟹壳粉和海马粉以及其他原料药加入重量倍数为9倍的水,煎煮两次,每次煎煮45分钟,煎煮后过滤;合并两次的滤液,浓缩至相对密度为1.00~1.10(60℃),得浓缩液,加入乙醇使乙醇的质量分数达65%,搅匀,静置36小时,过滤并回收乙醇,浓缩至相对密度为1.15~1.25(60℃)的稠膏;
步骤3:向步骤2制得的稠膏中加入辅料,混合,制粒,干燥,压片即得。
使用方法:用于预防,一次3片,一日3次;用于治疗,一次5片,一日3次,10日为一个疗程。
实施例2制备促进膀胱癌术后恢复的中药片剂
配方:
原料药:西洋参15克,黄精10克,当归15克,益母草15克,海马9克,枸杞20克,黄芪20克,蟹壳8克,炙甘草15克,木通16克,萹蓄12克,黄柏12克,连翘13克,熟地黄15克,生地黄10克,白芷12克,滑石5克,板蓝根25克,白茅根8克,黄芩10克,牵牛子10克。
辅料:麦芽糖糊精(粘合剂)6克,
羧甲基淀粉(崩解剂)6克,
滑石粉(助流剂)1克,
硬脂酸钙(润滑剂)1克
配制方法为:
步骤1:蟹壳培黄后研末,得蟹壳粉,海马研末得海马粉;
步骤2:将步骤1中得到的蟹壳粉和海马粉以及其他原料药加入重量倍数为9倍的水,煎煮两次,每次煎煮30分钟,煎煮后过滤;合并两次的滤液,浓缩至相对密度为1.00~1.10(60℃),得浓缩液,加入乙醇使乙醇的质量分数达65%,搅匀,静置48小时,过滤并回收乙醇,浓缩至相对密度为1.15~1.25(60℃)的稠膏;
步骤3:向步骤2制得的稠膏中加入辅料,混合,制粒,干燥,压片即得。
使用方法:用于预防,一次3片,一日3次;用于治疗,一次5片,一日3次,10日为一个疗程。
实施例3制备促进膀胱癌术后恢复的中药片剂
配方:
原料药:西洋参13克,黄精8克,当归12克,益母草10克,海马6克,枸杞17克,黄芪15克,蟹壳6克,炙甘草12克,木通13克,萹蓄10克,黄柏9克,连翘10克,熟地黄12克,生地黄8克,白芷8克,滑石3克,板蓝根20克,白茅根5克,黄芩8克,牵牛子7克。
辅料:淀粉(粘合剂)6克,
大豆多糖(崩解剂)6克,
水合硅铝酸钠(助流剂)1克,
聚乙二醇(润滑剂)1克
配制方法为:
步骤1:蟹壳培黄后研末,得蟹壳粉,海马研末得海马粉;
步骤2:将步骤1中得到的蟹壳粉和海马粉以及其他原料药加入重量倍数为9倍的水,煎煮两次,每次煎煮60分钟,煎煮后过滤;合并两次的滤液,浓缩至相对密度为1.00~1.10(60℃),得浓缩液,加入乙醇使乙醇的质量分数达65%,搅匀,静置24小时,过滤并回收乙醇,浓缩至相对密度为1.15~1.25(60℃)的稠膏;
步骤3:向步骤2制得的稠膏中加入辅料,混合,制粒,干燥,压片即得。
使用方法:用于预防,一次3片,一日3次;用于治疗,一次5片,一日3次,10日为一个疗程。
实施例4临床试验研究
给予本发明实施例1至3任一项的中药片剂,使用方法为:用于预防术后膀胱灌注引发的并发症,一次3片,一日3次,每次灌注自前一周开始给药,至灌注后一个月停止用药;用于治疗膀胱灌注引发的并发症,一次5片,一日3次,10日为一个疗程,症状消除后持续巩固用药一个月。
预防效果试验:
随机选取300名,年龄30-60岁,平均45岁,需做经尿道膀胱肿瘤电切术的非肌层浸润性膀胱肿瘤患者,每次自膀胱灌注卡介苗前一周开始给药,至灌注后一个月停止用药,坚持使用2年,期间,无一例患者出现尿路感染和其他卡介苗灌注引起的并发症,术后每3个月一次的膀胱镜复查,病人术后恢复状况良好,无复发迹象。
治疗效果试验:
随机选取100名由卡介苗膀胱灌注引起并发症的患者,年龄40-60岁,平均50岁,进行卡介苗膀胱灌注治疗3次以上,都有类此膀胱炎的症状,尿频尿急尿痛,其中,15位患者有尿血症状,18位患者尿路感染,35位患者有体虚盗汗的症状,10位患者有持续低热症状,5人有高热症状,13人有食欲不振症状,10人有头痛症状,12人有恶心呕吐症状,25位患者长期有肌肉酸痛的症状,1人出现结核性败血症症状。服用本发明片剂3个疗程后,25人并发症症状完全消除,69人症状明显好转,6人使用无效。
临床典型实施例:
1、陈某,35岁,男,经尿道膀胱肿瘤电切术后,进行卡介苗膀胱灌注治疗8次,出现尿频、尿急、尿痛,诊断为慢性膀胱炎,服用本发明片剂3个疗程后,尿频、尿急、尿痛消除,症状消除后持续服用本发明片剂1个月,慢性膀胱炎康复。
2、李某,50岁,女,经尿道膀胱肿瘤电切术后,进行卡介苗膀胱灌注治疗8次,出现尿频、尿急、尿痛、尿血和持续低热症状,服用本发明片剂3个疗程后,尿痛、尿血和持续低热症状消除,尿频、尿急症状明显好转。
3、齐某,58岁,男,经尿道膀胱肿瘤电切术后,进行卡介苗膀胱灌注治疗10次,出现尿频、尿急、尿痛、尿血、高烧不退、头痛、呕吐、食欲不振,诊断为膀胱炎和尿路感染,服用本发明片剂3个疗程后,尿血、高热、头痛、呕吐、食欲不振症状消除,尿频、尿急症状有所好转,尿路感染康复。
Claims (6)
1.一种促进膀胱癌术后恢复的中药片剂,由中药原料药和药物可接受的载体加工制备而成,其特征在于,所述中药片剂有效成分的原料药组成及重量份数为:西洋参8-15份,黄精5-10份,当归10-15份,益母草7-15份,海马3-9份,枸杞15-20份,黄芪10-20份,蟹壳3-8份,炙甘草8-15份,木通9-16份,萹蓄8-12份,黄柏6-12份,连翘8-13份,熟地黄7-15份,生地黄6-10份,白芷6-12份,滑石2-5份,板蓝根15-25份,白茅根3-8份,黄芩6-10份,牵牛子5-10份。
2.如权利要求1所述的促进膀胱癌术后恢复的中药片剂,其特征在于,所述中药片剂有效成分的原料药组成及重量份数为:西洋参8份,黄精5份,当归10份,益母草7份,海马3份,枸杞15份,黄芪10份,蟹壳3份,炙甘草8份,木通9份,萹蓄8份,黄柏6份,连翘8份,熟地黄7份,生地黄6份,白芷6份,滑石2份,板蓝根15份,白茅根3份,黄芩6份,牵牛子5份。
3.如权利要求1所述的促进膀胱癌术后恢复的中药片剂,其特征在于,所述中药片剂有效成分的原料药组成及重量份数为:西洋参15份,黄精10份,当归15份,益母草15份,海马9份,枸杞20份,黄芪20份,蟹壳8份,炙甘草15份,木通16份,萹蓄12份,黄柏12份,连翘13份,熟地黄15份,生地黄10份,白芷12份,滑石5份,板蓝根25份,白茅根8份,黄芩10份,牵牛子10份。
4.如权利要求1所述的促进膀胱癌术后恢复的中药片剂,其特征在于,所述中药片剂有效成分的原料药组成及重量份数为:西洋参13份,黄精8份,当归12份,益母草10份,海马6份,枸杞17份,黄芪15份,蟹壳6份,炙甘草12份,木通13份,萹蓄10份,黄柏9份,连翘10份,熟地黄12份,生地黄8份,白芷8份,滑石3份,板蓝根20份,白茅根5份,黄芩8份,牵牛子7份。
5.如权利要求1至4中任一项所述的促进膀胱癌术后恢复的中药片剂,其特征在于,所述药物可接受的载体包括:粘合剂,崩解剂,助流剂、润滑剂中的一种或两种;其中,所述粘合剂可以为淀粉、糊精、麦芽糖糊精、羧甲基纤维素、蔗糖、海藻酸及海藻酸盐、黄原胶;其中,所述崩解剂可以为交联聚乙烯吡咯烷酮、羧甲基淀粉和大豆多糖;其中,所述助流剂可以为微粉硅胶、滑石粉和水合硅铝酸钠;其中,所述润滑剂可以为硬脂酸镁、硬脂酸钙、聚乙二醇、氢化植物油。
6.如权利要求1所述的促进膀胱癌术后恢复的中药片剂的制备方法,其特征在于,包括以下步骤:
步骤1:蟹壳培黄后研末,得蟹壳粉,海马研末得海马粉;
步骤2:将步骤1中得到的蟹壳粉和海马粉以及其他原料药加入重量倍数为9倍的水,煎煮两次,每次煎煮30-60分钟,煎煮后过滤;合并两次的滤液,浓缩至60℃下相对密度为1.00~1.10,得浓缩液,加入乙醇使乙醇的质量分数达65%,搅匀,静置24~48小时,过滤并回收乙醇,浓缩至60℃下相对密度为1.15~1.25的稠膏;
步骤3:向步骤2制得的稠膏中加入所述药物可接受的载体,混合,制粒,干燥,压片即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410788961.3A CN104524275B (zh) | 2014-12-17 | 2014-12-17 | 一种促进膀胱癌术后恢复的中药片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410788961.3A CN104524275B (zh) | 2014-12-17 | 2014-12-17 | 一种促进膀胱癌术后恢复的中药片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104524275A CN104524275A (zh) | 2015-04-22 |
CN104524275B true CN104524275B (zh) | 2018-04-03 |
Family
ID=52840031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410788961.3A Expired - Fee Related CN104524275B (zh) | 2014-12-17 | 2014-12-17 | 一种促进膀胱癌术后恢复的中药片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524275B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105412490A (zh) * | 2016-01-09 | 2016-03-23 | 青岛辰达生物科技有限公司 | 一种用于治疗浅表性膀胱癌的药物制剂及其用途 |
US11793851B2 (en) * | 2020-09-03 | 2023-10-24 | Chen-Yu Lee | Method for treating a side effect caused by BCG perfusion therapy for bladder cancer |
CN114984158B (zh) * | 2022-07-21 | 2023-06-20 | 上海中医药大学附属龙华医院 | 一种预防非肌层浸润性膀胱癌术后复发的中药组合物及其制备方法和用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1421238A (zh) * | 2002-12-23 | 2003-06-04 | 丁铁岭 | 一种具有抗肿瘤、抗自由基损伤和调节免疫的天然生物反应调节剂 |
CN102727805A (zh) * | 2011-04-03 | 2012-10-17 | 王维德 | 一种治疗癌症的药物 |
CN104000946A (zh) * | 2014-06-18 | 2014-08-27 | 张财 | 一种治疗膀胱癌的外用中药 |
-
2014
- 2014-12-17 CN CN201410788961.3A patent/CN104524275B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1421238A (zh) * | 2002-12-23 | 2003-06-04 | 丁铁岭 | 一种具有抗肿瘤、抗自由基损伤和调节免疫的天然生物反应调节剂 |
CN102727805A (zh) * | 2011-04-03 | 2012-10-17 | 王维德 | 一种治疗癌症的药物 |
CN104000946A (zh) * | 2014-06-18 | 2014-08-27 | 张财 | 一种治疗膀胱癌的外用中药 |
Non-Patent Citations (2)
Title |
---|
膀胱癌;张洪亮 等;《新疆中医药》;20071231(第2期);63-64 * |
近年来中西结合治疗膀胱癌的研究进展;陈惠 等;《中华中医药学刊》;20140430;第32卷(第4期);740-741 * |
Also Published As
Publication number | Publication date |
---|---|
CN104524275A (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205024A (zh) | 一种治疗烧伤药膏及其制备方法 | |
CN103860591A (zh) | 一种用于痔疮脱落后生肌敛疮的外用苗药及其制备方法 | |
CN101143171B (zh) | 一种中药药物、其制备方法及其应用 | |
CN104524275B (zh) | 一种促进膀胱癌术后恢复的中药片剂及其制备方法 | |
CN103100016B (zh) | 一种治疗皮肤瘙痒症的中药 | |
CN103041033A (zh) | 一种治疗肾结石的中药组合物 | |
CN103611084B (zh) | 一种治疗疮疖药膏及其制备方法 | |
CN102784316B (zh) | 治烧烫伤、内外溃疡、白内障的抑癌生肌药及其制备方法 | |
CN104147524A (zh) | 一种治疗消化性溃疡病的中药制剂 | |
CN104043089A (zh) | 一种治疗痔疮的医用生物敷料栓 | |
CN107982387A (zh) | 一种治疗烫伤的中药组合物及其制备方法 | |
CN108096506A (zh) | 一种祛疣中药植物提取液及其制备方法 | |
CN105232849A (zh) | 一种治疗烧伤的膏药 | |
CN100355437C (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN104888178A (zh) | 一种治疗小儿腹泻的中药 | |
CN107929419A (zh) | 一种治疗烧烫伤的稠膏剂药物及制备方法 | |
CN107929492A (zh) | 一种治疗脓肿的壮医外用制剂及其制备方法 | |
CN107744549A (zh) | 一种治疗牙痛的药物及其制备方法 | |
CN106377613A (zh) | 一种治疗牛皮癣的外用药物及其制备方法 | |
CN105853931A (zh) | 一种用于护理冻疮的中药组合物 | |
CN103479917B (zh) | 一种治疗烧烫伤的中药组合物 | |
CN102000252B (zh) | 一种治疗血瘤的药及其制备方法 | |
CN103638174B (zh) | 一种喷涂治疗痔疮的中药 | |
CN104127741A (zh) | 一种治疗糖尿病的中药组方 | |
CN104740021A (zh) | 一种治疗脚气的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180403 Termination date: 20181217 |
|
CF01 | Termination of patent right due to non-payment of annual fee |